TheEdgeResearch
Home / Stocks / STMH

Stem Holdings, Inc. (STMH)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$67
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.91
52-Wk Range
0.000001-0.0305
CEO
Matthew J. Cohen
Country
US
Currency
USD

Stem Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Boca Raton, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $67. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 0.91 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
-0.45
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-1.36
Current ratio
0.95
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
75
IPO date
2021-01-08
Headquarters
Boca Raton, FL, US
About Stem Holdings, Inc.

Stem Holdings, Inc. operates as a fully integrated enterprise within the cannabis and technology sectors. Its core activities involve the cultivation, production, distribution, and sale of both cannabis and cannabis-derived products. The company manages a diverse brand portfolio, which includes TJ's Gardens, TravisxJames, and Yerba Buena for flower and extracts, as well as Cannavore for edible treats. For the broad consumer market, they offer Doseology, a CBD-focused brand. Additionally, their technological offerings comprise the e-commerce delivery platforms Budee and Ganjarunner. Established in 2016, the company's headquarters are located in Boca Raton, Florida.

Comparable companies

Stem Holdings, Inc. is most often compared with the following Healthcare names:

CSUIIDCNMSMYNGMCNPHCNRXCFPHCGPRCNFVIBEFVRTHF
More research on STMH
STMH technical analysis STMH TheEdge Score Compare against peers
Open full interactive analysis & DCF →